Reports
Sale
Global Allergy Treatment Market Share, Size, Analysis, Growth, Forecast: By Type: Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, Others; By Treatment: Anti-Allergy Drugs, Immunotherapy; By Route of Administration: Oral, Inhalation, Intranasal, Others; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Allergy Treatment Market Outlook
The global allergy treatment market size attained a value of USD 21.62 billion in 2023 driven by rising demand for Immunotherapy and Anti-Allergy Drugs. The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 to attain a value of USD 38.11 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Cases of Asthma and the Growing Risk of Allergies to Bolster the Growth of the Allergy Treatment Industry
The increasing demand for medical treatments to control asthma is anticipated to aid the market growth in the forecast period. The growing prevalence of asthma among children, geriatrics, and adults owing to the rising pollution levels is contributing to the demand for anti-allergy drugs and immunotherapy. Reckless attitude towards asthma or a lack of knowledge about allergy can lead to airway remodelling, which is a brutal condition. The increasing awareness about the various treatment options available to treat these conditions is likely to bolster the growth of the global allergy treatment industry.
North America Accounts for a Significant Share in the Market
The growing concerns about the need to counter allergies owing to the rising geriatric population are likely to be a major factor driving the allergy treatment industry growth in the region. In addition, the increasing healthcare expenditure and the development of clinics and hospitals in the region are significantly contributing to the market expansion. Furthermore, the market is expected to be aided by the availability of skilled medical professionals who specialise in asthma and eye allergy treatments in countries like the United States and Canada.
Allergy Treatment: Market Segmentation
Allergy treatment is defined as the process of treating an allergy using medicines or allergy shots, or by assisting an individual to avoid a particular substance to prevent further reactions. Allergy treatment may include options like antihistamines and avoiding allergens.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market is segmented into:
- Eye Allergy
- Rhinitis
- Asthma
- Skin Allergy
- Food Allergies
- Others
On the basis of treatment, the market is divided into:
- Anti-Allergy Drugs
- Immunotherapy
Among these, while the anti-allergy drugs segment is further divided into antihistamines, corticosteroids, decongestants, and other drugs, the immunotherapy segment is further categorised into sub-cutaneous immunotherapy (SCIT) and sub-lingual immunotherapy (SLIT) based on type.
The regional markets for allergy treatment include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Demand for Immunotherapy and Anti-Allergy Drugs to Boost the Growth of the Allergy Treatment Industry
The global allergy treatment industry is driven by the growing popularity of various anti-allergy drugs such as antihistamines, which are extremely beneficial for treating patients suffering from allergic reactions to pollen or other allergens. Antihistamines are also used to treat other conditions such as stomach problems, cold, and anxiety, among others. Furthermore, the market is anticipated to be augmented by the rising demand for immunotherapy owing to the fact that this type of treatment is ideal for long-term. The demand for immunotherapy is likely to be propelled by the surging cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others.
Key Industry Players in the Global Allergy Treatment Market
The report gives a detailed analysis of the following key players in the global allergy treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- AbbVie Inc.
- GlaxoSmithKline PLC
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services, Inc.
- Sanofi S.A.
- LETI Pharma, S.L.U.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Treatment |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Allergy Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Allergy Treatment Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Allergy Treatment Epidemiology (2016-2031)
5.3 Europe Allergy Epidemiology (2016-2031)
5.4 Asia-Pacific Allergy Epidemiology (2016-2031)
5.5 Latin America Allergy Epidemiology (2016-2031)
5.6 Middle East & Africa Allergy Epidemiology (2016-2031)
6 Global Allergy Treatment Market Overview
6.1 Global Allergy Treatment Market Historical Value (2017-2023)
6.2 Global Allergy Treatment Market Forecast Value (2024-2032)
7 Global Allergy Treatment Market Landscape
7.1 Allergy Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Allergy Treatment: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Treatment
7.2.3 Analysis by Route of Administration
7.2.4 Analysis by End User
8 Allergy Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Allergy Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Allergy Treatment Market Segmentation
11.1 Global Allergy Treatment Market by Type
11.1.1 Market Overview
11.1.2 Eye Allergy
11.1.3 Rhinitis
11.1.4 Asthma
11.1.5 Skin Allergy
11.1.6 Food Allergies
11.1.7 Others
11.2 Global Allergy Treatment Market by Treatment
11.2.1 Market Overview
11.2.2 Anti-Allergy Drugs
11.2.2.1 Antihistamine
11.2.2.2 Corticosteroids
11.2.2.3 Decongestants
11.2.2.4 Other Drugs
11.2.3 Immunotherapy
11.2.3.1 Sub-Cutaneous Immunotherapy (SCIT)
11.2.3.2 Sub-Lingual Immunotherapy (SLIT)
11.3 Global Allergy Treatment Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Inhalation
11.3.4 Intranasal
11.3.5 Others
11.4 Global Allergy Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Homecare
11.4.5 Others
11.5 Global Allergy Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Allergy Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Allergy Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Allergy Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Allergy Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Allergy Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 AbbVie Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Sanofi S.A.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Johnson & Johnson Services, Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 LETI Pharma, S.L.U.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 GlaxoSmithKline Plc.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Zenomed Healthcare Private Limited
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 F. Hoffmann-La Roche AG
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Cadila Pharmaceuticals
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Bayer AG
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Teva Pharmaceutical Industries Ltd.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Akorn, Incorporated
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Prestige Consumer Healthcare Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Astellas Pharma Inc.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Eli Lilly and Company
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 Almirall, S.A
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
24 Allergy Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
Globally, allergy treatment market reached a value of USD 21.62 billion in 2023.
The market is projected to expand at a CAGR of 6.5% from 2024 to 2032, growing to USD 38.11 billion by 2032.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the industry, such as the rising cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others, growing demand for immunology and anti-allergy drugs, the rising healthcare expenditure in emerging economies, and the growing awareness about the fatality of allergies, among others, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing investments in R&D activities in the field of medicine, along with the technological advancements in the healthcare infrastructure in emerging economies.
Eye allergy, rhinitis, asthma, skin allergy, and food allergies, among others are the major allergy treatment types.
Anti-allergy drugs and immunotherapy are the different kinds of treatments considered within the market report.
The major players in the industry are AbbVie Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Sanofi S.A., and LETI Pharma, S.L.U., among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER